Skip to main content
. 2023 Apr 4:M22-1286. doi: 10.7326/M22-1286

Visual Abstract. Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19.

Visual Abstract.

Treatment guidelines and emergency use authorizations for monoclonal antibodies (mAbs) for treatment of COVID-19 have changed frequently as different SARS-CoV-2 variants have emerged. This study evaluated whether early outpatient treatment with mAbs is associated with reduced risk for hospitalization or death at 28 days.